Humana Inc. reaffirms its full year 2023 adjusted EPS guidance of at least $28.25 and Insurance segment benefit expense ratio guidance of 86.3% to 87.3%, but expects to be at the top end of the range due to higher utilization trends and strong individual Medicare Advantage growth.